Furthermore, Western blotting confirmed lower expression of oncogenic markers, stemness markers, CAF markers (α-SMA), and PROX1 as well as lower expression of ABCG2 in the PROX1-knockdown tumor samples as compared with vector control (Figure 7D). The gene discussed is PROX1; the disease is neoplasm.